Intalere Members Benefit through New Agreement with Medivant Healthcare for Sterile Liquid Injectables
St. Louis (January 20, 2021) – Intalere, the healthcare industry leader in delivering solutions designed for improved financial, operational and clinical health for our partners, announces a new pharmaceutical agreement with Medivant Healthcare.
Through this agreement, Intalere members will receive negotiated pricing on sterile single dose liquid injectable medications. Medivant Healthcare offers real-time ordering and inventory, quality products made in the USA, in-house WFI (Water-for-Injection) System, and a comprehensive Credit Return Policy offering up to 90% credit on the value of expired product. Specializing in single dose vials, they have in-stock product available for order, as well as an extensive list of products available for pre-order.
This contract is currently effective through November 30, 2023.
About Medivant Healthcare
Based in Chandler, Arizona, Medivant Healthcare is a boutique, FDA Registered cGMP (Current Good Manufacturing Practice) compliant manufacturer currently licensed as a 503B, guided by automation that naturally leads to greater output. Learn more at www.medivanthealth.com.
Intalere’s mission focuses on elevating the health of healthcare by designing solutions to improve our members’ financial, operational and clinical performance. We empower our customers and deliver measurable results through our highly personalized approach of creating strategies and programs focused on their goals. From managing their entire spend to strategic consulting around diagnosing particular areas of concern, our unique provider led model allows us to leverage nationally recognized best practices in supply chain and patient outcomes to drive efficiencies for our members. To learn more, visit www.intalere.com.